Tolerability Data for Shire's CUVITRU Accepted for Oral Presentation at the American College Of Allergy, Asthma & Immunology Annual Meeting

12. November 2016 INDIZES USA

Data reveals key findings on the tolerability of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] for patients …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...